Cifcibasi Emine, Kantarci Alpdogan, Badur Selim, Issever Halim, Cintan Serdar
Department of Periodontology, Faculty of Dentistry, Istanbul University, Istanbul, Turkiye.
The Forsyth Intitute, Boston, MA, USA.
Eur J Dent. 2015 Jan-Mar;9(1):53-59. doi: 10.4103/1305-7456.149642.
Generalized aggressive periodontitis (GAgP) is a complex periodontal disease affecting the entire dentition with a rapid destruction of the periodontium and resulting in loss of teeth. We hypothesized that better clinical healing of adjunctive use of amoxicillin plus metronidazole combination may be related to the effect of this combination therapy to restore imbalance between matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) which is associated with connective tissue and alveolar bone destruction in patients with GAgP.
Twenty-eight subjects diagnosed with GAgP were recruited. Patients were randomly assigned to test or control groups. MMP-1/TIMP-1 ratio was compared between groups receiving scaling and root planning (SRP) alone (control) or in combination with amoxicillin plus metronidazole (test). Clinical periodontal variables were measured. Gingival crevicular fluid samples were obtained and analyzed for MMP-1 and TIMP-1. Measurements were taken at baseline and repeated at 3 and 6 months after therapy.
Total MMP-1 levels were significantly decreased in both groups (P < 0.05) at 3 and 6 months. MMP-1 concentration levels showed a similar pattern to MMP-1 total levels decreasing significantly at 3 months (P < 0.05). TIMP-1 concentration levels increased in the test group throughout the study period, while the difference did not reach statistical significance (P > 0.05). TIMP-1/MMP-1 balance was restored in test group at 6 months significantly better than the control group (P < 0.05).
The results of this study suggest that metronidazole and amoxicillin combination as an adjunct to SRP results in better clinical healing through restoring TIMP-1/MMP-1 balance.
广泛侵袭性牙周炎(GAgP)是一种复杂的牙周疾病,影响全口牙列,导致牙周组织迅速破坏并造成牙齿缺失。我们推测,阿莫西林联合甲硝唑辅助治疗能实现更好的临床愈合,可能与该联合疗法恢复基质金属蛋白酶(MMP)及其组织抑制剂(TIMP)之间失衡的作用有关,这种失衡与GAgP患者的结缔组织和牙槽骨破坏相关。
招募了28名被诊断为GAgP的受试者。患者被随机分配到试验组或对照组。比较单独接受龈下刮治和根面平整(SRP)(对照组)或联合阿莫西林加甲硝唑治疗(试验组)的两组之间的MMP-1/TIMP-1比值。测量临床牙周变量。获取龈沟液样本并分析其中的MMP-1和TIMP-1。在基线时进行测量,并在治疗后3个月和6个月重复测量。
两组在3个月和6个月时总MMP-1水平均显著降低(P < 0.05)。MMP-1浓度水平呈现与总MMP-1水平相似的模式,在3个月时显著降低(P < 0.05)。在整个研究期间,试验组TIMP-1浓度水平升高,但其差异未达到统计学意义(P > 0.05)。试验组在6个月时TIMP-1/MMP-1平衡的恢复明显优于对照组(P < 0.05)。
本研究结果表明,甲硝唑和阿莫西林联合作为SRP的辅助治疗,通过恢复TIMP-1/MMP-1平衡可实现更好的临床愈合。